In controlled programs that paired medication with lifestyle support, patients achieved substantial, measurable change: in a 68-week trial, participants taking semaglutide lost an average of 14.9% of their body weight, according to Advances in Therapy, reflecting the drugs magnitude of effect when combined with structured behavior change
Some studies failed to demonstrate significant differences in insulin resistance between patients with androgenic alopecia and controls, while others found a clear connection between insulin resistance and androgenic alopecia
Clinical data suggest meaningful body-weight reductions over time when Semaglutide is combined with consistent dietary, activity, and behavioral changes, which Better Med Spa supports through ongoing follow-up and coaching
Whilst all of our content is written and reviewed by healthcare professionals, it is not intended to be substituted for or used as medical advice
